“Double-Blind Study of Naltrexone and Placebo in the Treatment of Pathological Gambling Disorder”

Principal Investigator: Suck Won Kim, MD, University of Minnesota Medical School
Awarded $53,374 in 1998

Aim: Test efficacy of naltrexone, a drug used to blunt cravings for alcohol, for treating pathological gambling. In 2002, the lead investigator was awarded $464,463 by the National Institute of Mental Health to expand this study.

Kim, S.W. & Grant, J.E. (2001). An open naltrexone treatment study in pathological gambling disorder. International Clinical Psychopharmacology, 16, 285-289.

Kim, S.W. & Grant, J.E. (2001). The psychopharmacology of pathological gambling. Seminars in Clinical Neuropsychiatry, 6, 184-194.

Kim, S.W., Grant, J.E. & Adson, D.E. (2001). Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biological Psychiatry, 49, 914-921

Year: 1998
Type: Project Grants